129 related articles for article (PubMed ID: 31413881)
1. The Role of Recombinant Human Cyclophilin A in the Antitumor Immune Response.
Kalinina AA; Silaeva YY; Kazansky DB; Khromykh LM
Acta Naturae; 2019; 11(2):63-67. PubMed ID: 31413881
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A is a factor of antitumor defense in the early stages of tumor development.
Kalinina A; Golubeva I; Kudryavtsev I; Khromova N; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
Int Immunopharmacol; 2021 May; 94():107470. PubMed ID: 33640856
[TBL] [Abstract][Full Text] [Related]
4. Preparative Production and Purification of Recombinant Human Cyclophilin A.
Kalinina AA; Kolesnikov AV; Kozyr AV; Kulikova NL; Zamkova MA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2022 Mar; 87(3):259-268. PubMed ID: 35526853
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
[TBL] [Abstract][Full Text] [Related]
6. Analyses of the toxic properties of recombinant human Cyclophilin A in mice.
Kalinina A; Zamkova M; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
J Immunotoxicol; 2019 Dec; 16(1):182-190. PubMed ID: 31646917
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis.
Perrucci GL; Straino S; Corlianò M; Scopece A; Napolitano M; Berk BC; Lombardi F; Pompilio G; Capogrossi MC; Nigro P
Int J Cardiol; 2016 Jun; 212():324-35. PubMed ID: 27057951
[TBL] [Abstract][Full Text] [Related]
8. trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
Saphire AC; Bobardt MD; Gallay PA
J Virol; 2002 Mar; 76(5):2255-62. PubMed ID: 11836403
[TBL] [Abstract][Full Text] [Related]
9. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
Ke H; Mayrose D; Belshaw PJ; Alberg DG; Schreiber SL; Chang ZY; Etzkorn FA; Ho S; Walsh CT
Structure; 1994 Jan; 2(1):33-44. PubMed ID: 8075981
[TBL] [Abstract][Full Text] [Related]
11. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.
Davra V; Saleh T; Geng K; Kimani S; Mehta D; Kasikara C; Smith B; Colangelo NW; Ciccarelli B; Li H; Azzam EI; Kalodimos CG; Birge RB; Kumar S
Mol Cancer Res; 2020 Aug; 18(8):1189-1201. PubMed ID: 32321766
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Human Cyclophilin A in Combination with Adoptive T-cell Therapy Improves the Efficacy of Cancer Immunotherapy in Experimental Models in vivo.
Kalinina AA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2023 May; 88(5):590-599. PubMed ID: 37331705
[TBL] [Abstract][Full Text] [Related]
14. Evidences of monomer, dimer and trimer of recombinant human cyclophilin A.
Zhang XC; Wang WD; Wang JS; Pan JC; Zou GL
Protein Pept Lett; 2011 Dec; 18(12):1188-93. PubMed ID: 21728990
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory cyclophilin a improves low-dose chemotherapy with a modulation of the immune tumor microenvironment in experimental models of melanoma B16 and lymphoma EL4 in vivo.
Kalinina AA; Tilova LR; Kazansky DB; Khromykh LM
Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38913118
[TBL] [Abstract][Full Text] [Related]
16. CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy.
Chu MY; Huang HC; Li EM; Xu LY
Curr Med Chem; 2021; 28(19):3787-3802. PubMed ID: 33121398
[TBL] [Abstract][Full Text] [Related]
17. Secreted cyclophilin A is non-genotoxic but acts as a tumor promoter.
Kalinina A; Tilova L; Kirsanov K; Lesovaya E; Zhidkova E; Fetisov T; Ilyinskaya G; Yakubovskaya M; Kazansky D; Khromykh L
Toxicology; 2023 Dec; 500():153675. PubMed ID: 37993081
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A Regulates Influenza A Virus-induced Macrophages Polarization and Inflammatory Responses by Targeting Cyclophilin A.
Bai X; Yang W; Li H; Zhao Y; Fan W; Zhang H; Liu W; Sun L
Front Immunol; 2022; 13():861292. PubMed ID: 35693825
[TBL] [Abstract][Full Text] [Related]
19. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorescent localization and immunochemical determination of cyclophilin-A with specific rabbit antisera.
Sarris AH; Harding MW; Jiang TR; Aftab D; Handschumacher RE
Transplantation; 1992 Nov; 54(5):904-10. PubMed ID: 1440857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
